China NT Pharma Group Company Limited (01011.HK) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 19Aug 24Aug 27Sep 1Sep 4Sep 9Sep 14Sep 17

Key dataSep 17, 2026

OpenHKD 0.42

From 52W high−70.25%

Volume50000.00

Market capHKD 243.26M

P/E (TTM)—

P/S (TTM)5.9x

Div yield—

Key dataSep 17, 2026

Open

HKD 0.42

From 52W high

−70.25%

Volume

50000.00

Market cap

HKD 243.26M

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−44.8x

P/E (TTM)

—

RSI (14)

43.2

MomentumView details →

1D Return

+0.00%

YTD Return

−56.10%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

−44.8x

EV/Sales

16.6x

P/S (TTM)

5.9x

P/B (TTM)

−1.9x

ProfitabilityView details →

Gross Margin

16.46%

Net Margin

−76.94%

EBITDA Margin

−37.18%

ROE (TTM)

24.55%

ROA (TTM)

−4.25%

Asset Turnover

0.07x

GrowthView details →

Revenue YoY

+90.27%

EPS YoY

+84.54%

FCF YoY

+75.81%

Revenue CAGR 3Y

−51.14%

EPS CAGR 3Y

+78.90%

EBITDA YoY

−79.52%

MomentumView details →

1D Return

+0.00%

YTD Return

−56.10%

1Y Return

−68.97%

RSI (14)

43.2

vs 50D SMA

−4.36%

vs 200D SMA

−41.42%

Capital & dividendView details →

Debt/Equity

−3.01x

Current Ratio

0.05x

Quick Ratio

0.04x

Div Yield

—

Div Rate

—

Div Growth 1Y

+40.00%

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

54.16M

Net Income (TTM)

−98.24M

Op. CF (TTM)

−27.88M

Latest newsMore news →

Zhongke Tianyuan issued a profit warning, expecting its attributable loss for the six months ending June 2026 to narrow to approximately RMB 3.72 million from RMB 7.85 million a year earlier.27d ago

Tailing Medicine reported interim results for the six months ended June 2026, with revenue up 97.3% year-on-year to RMB 23.67 million and net loss widening to RMB 18.43 million from RMB 16.91 million a year earlier.31d ago

Similar companies

Aurora Cannabis Inc.ACB Tianda Pharmaceuticals Limited00455.HK Cardiol Therapeutics Inc.CRDL SIGA Technologies, Inc.SIGA Journey Medical CorporationDERM Extrawell Pharmaceutical Holdings Limited00858.HK Find similar companies →

Latest newsMore news →

Zhongke Tianyuan issued a profit warning, expecting its attributable loss for the six months ending June 2026 to narrow to approximately RMB 3.72 million from RMB 7.85 million a year earlier.27d ago Tailing Medicine reported interim results for the six months ended June 2026, with revenue up 97.3% year-on-year to RMB 23.67 million and net loss widening to RMB 18.43 million from RMB 16.91 million a year earlier.31d ago